BioInvent International AB (publ) (BOVNF)
USD 4.7
(0.0%)
USD 4.7
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 14.53 Million USD | -22.57% |
| 2022 | 18.77 Million USD | -12.81% |
| 2021 | 21.53 Million USD | 282.32% |
| 2020 | 5.63 Million USD | 456.84% |
| 2019 | 1.01 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | - USD | 0.0% |
| 2024 Q2 | 10.4 Million SEK | 0.0% |
| 2024 Q1 | 12.47 Million SEK | 0.0% |
| 2023 Q4 | 14.53 Million USD | 8.0% |
| 2023 FY | 14.53 Million USD | -22.57% |
| 2023 Q3 | 13.45 Million USD | -11.26% |
| 2023 Q2 | 15.16 Million USD | -10.07% |
| 2023 Q1 | 16.86 Million USD | -10.17% |
| 2022 Q2 | - USD | 0.0% |
| 2022 FY | 18.77 Million USD | -12.81% |
| 2022 Q4 | 18.77 Million USD | 1121.5% |
| 2022 Q3 | 1.53 Million USD | 0.0% |
| 2021 FY | 21.53 Million USD | 282.32% |
| 2020 FY | 5.63 Million USD | 456.84% |
| 2019 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | - USD | -Infinity% |
| Nanobac Pharmaceuticals, Incorporated | - USD | -Infinity% |
| SQZ Biotechnologies Company | 20.9 Million USD | 30.484% |
| Evofem Biosciences, Inc. | 8000.00 USD | -181587.5% |
| Santhera Pharmaceuticals Holding AG | 1.75 Million USD | -727.979% |
| Mesoblast Limited | 100.29 Million USD | 85.508% |
| Propanc Biopharma, Inc. | 58.64 Thousand USD | -24685.99% |
| Genus plc | 228.2 Million USD | 93.631% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| CNBX Pharmaceuticals Inc. | - USD | -Infinity% |
| Marizyme, Inc. | 667.12 Thousand USD | -2078.739% |
| ContraFect Corporation | 2.21 Million USD | -557.692% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| PsyBio Therapeutics Corp. | - USD | -Infinity% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.4 Million USD | -936.043% |
| Intellipharmaceutics International Inc. | - USD | -Infinity% |
| AXIM Biotechnologies, Inc. | 5.42 Million USD | -167.853% |
| MultiCell Technologies, Inc. | 36.43 USD | -39898335.355% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 55.61 Million USD | 73.864% |
| EV Biologics, Inc. | - USD | -Infinity% |
| Q BioMed Inc. | - USD | -Infinity% |
| Emmaus Life Sciences, Inc. | 2.22 Million USD | -552.965% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| Mosaic ImmunoEngineering Inc. | 1.22 Million USD | -1083.284% |
| Biomind Labs Inc. | - USD | -Infinity% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 166.1 Million USD | 91.25% |
| Oncotelic Therapeutics, Inc. | 1.89 Million USD | -665.617% |
| Skye Bioscience, Inc. | 171.23 Thousand USD | -8388.583% |
| Therapeutic Solutions International, Inc. | 5512.00 USD | -263597.388% |
| THC Farmaceuticals, Inc. | - USD | -Infinity% |
| Arch Therapeutics, Inc. | - USD | -Infinity% |
| IMV Inc. | 27.39 Million USD | 46.95% |
| Acro Biomedical Co., Ltd. | - USD | -Infinity% |
| Curative Biotechnology, Inc. | - USD | -Infinity% |
| GB Sciences, Inc. | 322 Thousand USD | -4413.975% |
| Alpha Cognition Inc. | - USD | -Infinity% |
| HST Global, Inc. | - USD | -Infinity% |
| CSL Limited | 11.23 Billion USD | 99.871% |
| Halberd Corporation | 150 Thousand USD | -9590.0% |
| Enzolytics Inc. | - USD | -Infinity% |
| Resverlogix Corp. | - USD | -Infinity% |
| Affymax, Inc. | - USD | -Infinity% |
| SYBLEU INC | 300 Thousand USD | -4745.0% |
| Nuo Therapeutics, Inc. | 164.2 Thousand USD | -8751.74% |
| argenx SE | 15.35 Million USD | 5.334% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 20.31 Million USD | 28.441% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | - USD | -Infinity% |
| Zenith Capital Corp. | 4456.00 USD | -326089.408% |
| Genscript Biotech Corporation | 287.12 Million USD | 94.938% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 126.3 Thousand USD | -11408.131% |
| WPD Pharmaceuticals Inc. | 229.29 Thousand USD | -6239.106% |
| American Oriental Bioengineering, Inc. | 554.59 Thousand USD | -2520.855% |
| Provectus Biopharmaceuticals, Inc. | 25.29 Thousand USD | -57352.864% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | - USD | -Infinity% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 8.26 Million USD | -75.883% |
| Cotinga Pharmaceuticals Inc. | - USD | -Infinity% |
| BioStem Technologies, Inc. | 265.63 Thousand USD | -5371.794% |
| ONE Bio Corp. | 592.19 Thousand USD | -2354.416% |
| Reve Technologies, Inc. | 1064.00 USD | -1365971.429% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Agentix Corp. | - USD | -Infinity% |
| LadRx Corporation | - USD | -Infinity% |
| Cell Source, Inc. | - USD | -Infinity% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Regen BioPharma, Inc. | 149.61 Thousand USD | -9615.0% |
| Regen BioPharma, Inc. | 149.61 Thousand USD | -9615.0% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | - USD | -Infinity% |
| Itoco Inc. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| Kadimastem Ltd | 229.69 Thousand USD | -6228.067% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| CytoDyn Inc. | 141 Thousand USD | -10208.511% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | 80 Thousand USD | -18068.75% |
| Alseres Pharmaceuticals, Inc. | 7.81 Million USD | -85.871% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | - USD | -Infinity% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 369.04 Thousand USD | -3838.501% |
| International Stem Cell Corporation | 445 Thousand USD | -3166.292% |
| Bioxytran, Inc. | - USD | -Infinity% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 8.15 Million USD | -78.344% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | 457 Thousand USD | -3080.525% |
| Neutra Corp. | - USD | -Infinity% |
| Windtree Therapeutics, Inc. | 1.16 Million USD | -1151.938% |
| PureTech Health plc | 18.25 Million USD | 20.356% |
| Coeptis Therapeutics, Inc. | 150 Thousand USD | -9590.0% |
| IXICO plc | 275 Thousand USD | -5185.455% |
| IntelGenx Technologies Corp. | 11.83 Million USD | -22.772% |
| Gelesis Holdings, Inc. | 26.3 Million USD | 44.753% |
| CSL Limited | 11.23 Billion USD | 99.871% |
| Cellectis S.A. | 36.21 Million USD | 59.86% |